Trial
NCT01919190
EXPAREL Administered by Infiltration Into the TAP for Prolonged Postsurgical Analgesia in Lower Abdominal Surgeries
Phase IVTERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Pacira Pharmaceuticals, Inc
Collaborators
—
Condition
Pain
Intervention
EXPAREL
Why stopped
Due to reasons unrelated to safety; primary endpoint signal seen during pre-specified interim analysis.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-07-02